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Diverse Signaling Pathways Activated by Growth
Factor Receptors Induce Broadly Overlapping,
Rather Than Independent, Sets of Genes
dimerize and autophosphorylate various cytoplasmic ty-
rosines. These phosphorylated tyrosines consequently
become binding sites for a variety of intracellular mole-
cules. Some bind SH2 domain±containing proteins such
as phospholipase Cg 1 (PLCg1), phosphatidylinositol
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²Schepens Eye Research Institute 39-kinase p85 subunit (PI3K), Ras GTPase±activating
protein (RasGAP), the SHP2 phosphatase, and the Src20 Staniford Street
Boston, Massachusetts 02114 class kinases Src, Fyn, and Yes (see references below).
Some act as binding sites for SH2-SH3 adaptor proteins,³Department of Biology
Massachusetts Institute of Technology such as Grb2, Grb7, Shc, and Nck, which link the recep-
tor to other signaling molecules, such as the Ras gua-Cambridge, Massachusetts 02139
nine nucleotide exchange factor SOS. The cytoplasmic
signaling molecules become activated by binding to the
receptor, either by allowing them to become phosphory-Summary
lated by the RTK or by concentrating them at the inner
face of the cell membrane, thus promoting certain pro-We sought to explore the relationship between recep-
tein±protein and protein±lipid interactions. In this fash-tor tyrosine kinase (RTK) activated signaling pathways
ion, the phosphorylated tyrosines initiate signal trans-and the transcriptional induction of immediate early
duction through a diverse array of signaling pathways,genes (IEGs). Using global expression monitoring, we
including the Ras pathway, the PLCg pathway, and theidentified 66 fibroblast IEGs induced by platelet-
PI3K pathway.derived growth factor b receptor (PDGFRb) signaling.
A fundamental question about signal transduction is,Mutant receptors lacking binding sites for activation
How do these various signaling pathways interact toof the PLCg, PI3K, SHP2, and RasGAP pathways still
communicate the message of RTK activation? Focusingretain partial ability to induce 64 of these IEGs. Re-
specifically on gene induction, How do the pathwaysmoval of the Grb2-binding site further broadly reduces
interact to induce the IEGs? Two extreme alternativesinduction. These results suggest that the diverse path-
would be that (i) distinct ªmodulesº of IEGs are inducedways exert broadly overlapping effects on IEG induc-
by specific pathways or (ii) each IEG depends on no singletion. Interestingly, a mutant receptor that restores the
pathway, but rather receives input from every pathway. ARasGAP-binding site promotes induction of an inde-
wide range of intermediate models, of course, could liependent group of genes, normally induced by interfer-
between these poles.ons. Finally, we compare the PDGFRb and fibroblast
Some evidence suggesting that signaling pathwaysgrowth factor receptor 1; each induces essentially
induce distinct IEG modules has been reported in theidentical IEGs in fibroblasts.
literature. For example, it has been proposed that, fol-
lowing activation of platelet-derived growth factor recep-
tor in fibroblasts, c-myc is primarily induced by signalingIntroduction
through Src family kinases (Barone and Courtneidge,
1995), while c-fos transcription is primarily induced byReceptor tyrosine kinases (RTKs) transduce key extra-
signaling through SHP2, PLCg, and Shc via the Rascellular signals that trigger cellular events, such as mito-
pathway, but not by signaling through PI3K, Nck, or Srcsis and cytoskeletal rearrangement, and thereby orches-
family kinases (Hill and Treisman, 1995; Roche et al.,trate physiological processes, such as development,
1996). Other data suggest that junB and KC are down-wound repair, and oncogenesis. RTKs mediate these
stream of PLCg, but not PI3K, SHP2, RasGAP, or Srcresponses by activating, upon ligand binding, a variety
family kinases (Montmayeur et al., 1997). On the otherof intracellular signaling pathways through an intrinsic
hand, independent signaling to distinct modules of IEGskinase activity (van der Geer et al., 1994). Such signaling
cannot be true in the strictest sense. Some signalingresults in the transcription of a set of ªimmediate early
pathways are known to have sites of convergence, andgenesº (IEGs), whose induction does not require protein
some IEG promoters are known to be responsive tosynthesis and thus involves latent transcriptional activa-
multiple distinct inputs. For example, both PI3K andtors already present in cells (Rollins and Stiles, 1989;
SHP2 can cause activation of the Ras pathway. How-Herschman, 1991). IEG products, many of which are
ever, PI3K also activates signaling through Akt, by atranscriptional regulators or secreted signaling mole-
distinct and separable mechanism, and this Akt pathwaycules, subsequently initiate cellular processes that de-
could have its own distinct transcriptional outputs (Bon-pend on protein synthesis, such as mitogenesis.
deva et al., 1998). Only a few IEG promoters have beenThe signaling process by which RTK activation stimu-
analyzed in detail, such as the c-fos promoter, whichlates IEGs is quite complex. Upon ligand binding, RTKs
responds to multiple signaling pathways. Evidence that
multiple pathways contribute to the induction of c-fos,
however, may not be surprising inasmuch as it is among§ To whom correspondence should be addressed (e-mail: lander@
wi.mit.edu). the most promiscuously inducible genes known. For the
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vast majority of IEGs, there are no data concerning pro- exogenous activities, such as drugs, antisense con-
structs, inhibitory antibodies, or conditional expressionmoter structure and function.
We sought to explore the question of the dependence systems, that may have pleiotropic effects on IEG ex-
pression.of IEG induction on the various signaling pathways from
a more global perspective. Ideally, one would like to Here, we report evidence suggesting that PDGFRb-
activated signaling pathways induce broadly overlap-identify the complete set of IEGs induced by an RTK and
then study how their induction is altered by eliminating ping groups of IEGs, as opposed to independent mod-
ules of IEGs. Specifically, we use global expressionactivation of specific signaling pathways. With the re-
cent advent of expression microarrays (Schena et al., monitoring to show that nearly all of 66 IEGs induced
by a chimeric RTK including the cytoplasmic domain of1995; Lockhart et al., 1996), it is possible to approach
this ideal experiment by performing expression monitor- the PDGFRb still show measurable induction by a mu-
tant receptor lacking five critical cytoplasmic tyrosineing of thousands of genes simultaneously. One can iden-
tify a large collection of IEGs and then examine their residues implicated in RasGAP, PI3K, SHP2, and PLCg
signaling. Removal of an additional tyrosine that servesinduction by mutant RTKs that fail to activate various
signaling pathways. as a Grb2-binding site further broadly affects induction
for most IEGs. Interestingly, however, a distinct moduleWe focused our attention on the PDGFRb, because
it has been well studied with respect to the activation of genes not normally induced by PDGFRb can be in-
duced by a receptor that retains the RasGAP-bindingof signaling pathways as well as the induction of IEG
expression (reviewed in Heldin et al., 1998). Activated site but lacks sites for PI3K, SHP2, and PLCg. Thus, a
specific RTK-activated signaling pathway can indepen-PDGFRbs are known to bind signaling molecules at spe-
cific tyrosine residues: PLCg1 at tyrosine 1021; PI3K at dently induce a specific module of genes, at least in this
setting. We also show that the set of IEGs induced bytyrosines 740 and 751; RasGAP at tyrosine 771; SHP2
at tyrosine 1009; the Src class kinases Src, Fyn, and the PDGF and FGF receptors are virtually identical, while
the EGF receptor induces only a subset of these genes.Yes at tyrosines 579 and 581; and STAT5 at tyrosines
579, 581, and 775. Adaptor proteins such as Grb2, which
binds at tyrosine 716, and Grb7, Nck, and Shc also bind Results
to the activated receptor. Other classes of signaling
proteins have also been reported to bind activated Construction of Chimeric Growth Factor Receptors
PDGFRs with unknown sequence specificity, such as Ja- that Permit the Analysis of PDGFRb
nus (Jak) kinases, additional STAT proteins, c-Fer, and Signaling in Fibroblasts
a Rho class GTPase (Fantl et al., 1992; Kashishian et Platelet-derived growth factor is a major in vivo mitogen
al., 1992; Kazlauskas et al., 1992, 1993; RoÈ nnstrand et for fibroblasts. Fibroblasts express two different forms
al., 1992; Kashishian and Cooper, 1993; Mori et al., 1993; of the PDGFR, a and b, which are closely related and can
Nishimura et al., 1993; Valius et al., 1993; Arvidsson et both homodimerize and heterodimerize upon binding to
al., 1994; Yokote et al., 1994, 1996; Kim and Wong, 1995; PDGF dimers. We decided to focus our work on the
Zubiaur et al., 1995; Vignais et al., 1996; Montmayeur et function of PDGFRb in fibroblasts, because it has been
al., 1997; ValgeirsdoÂ ttir et al., 1998). intensively studied with respect to the initiation of intra-
Studies in multiple cell types have shown that cellular signaling.
PDGFRbs carrying tyrosine to phenylalanine (Y→F) mu- To bypass endogenous PDGFRs in fibroblasts, we
tations at the critical residues fail to bind the associated generated a set of chimeric PDGFRbs with altered ligand
signaling molecules and, furthermore, that the signaling binding specificity. The M-CSF receptor and PDGFRb
pathways are not activated. Specifically, biochemical are highly related RTKs of the same subfamily but with
studies in human HepG2 cells (Valius and Kazlauskas, different ligand binding specificity (van der Geer et al.,
1993; Chung et al., 1994), A431 cells (Valius et al., 1995; 1994). Fibroblasts have no endogenous M-CSF binding
Montmayeur et al., 1997), canine TRMP cells (Franke et activity and show no biological response to M-CSF (see
al., 1995), and murine Ph 3T3-like cells (DeMali et al., below). Accordingly, we constructed a gene encoding a
1997) analyzed the activation of various signaling mole- chimeric receptor protein that contains the extracellular
cules by PDGFRbs carrying Y→F mutations. These stud- ligand-binding domain of the human M-CSF receptor,
ies all show that Y→F mutations are effective in blocking and the transmembrane and cytoplasmic signaling do-
activation of signaling pathways following receptor acti- mains of the human PDGFRb (Figure 1A; Symes and
vation, as opposed to such mutations merely blocking Mercola, 1996). This chimeric receptor thus has the sig-
association of signaling molecules with the receptor. naling activity of PDGFRb but is activated by binding
We took advantage of the ability of Y→F mutations in M-CSF. We refer to this as the ªwild-typeº chimeric
the PDGFRb to block activation of downstream signaling receptor, denoted ChiR(WT), because the PDGFRb cy-
molecules to investigate IEG induction by signaling toplasmic signaling domain is intact.
pathways following receptor activation. By combining Several mutant ChiR genes were then constructed
multiple Y→F mutations on a single receptor, one can that encode combinations of Y→F mutations in the intra-
focus on the signaling activity of a particular pathway. cellular signaling domain. In wild-type PDGFRbs, these
Such multiply mutated PDGFRbs have been widely used tyrosines are phosphorylated upon ligand binding and
to assess the contribution of different signaling path- consequently become binding sites for the activation
ways to various cellular and biochemical responses of signaling molecules that contain SH2 domains (see
(e.g., Valius and Kazlauskas, 1993; Joly et al., 1994; Introduction; Heldin et al., 1998). Mutant receptors that
contain phenylalanine at these positions cannot be phos-Kundra et al., 1994). The method is simple and avoids
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Figure 1. Chimeric Growth Factor Receptor Structure, Expression, and Mitogenesis
(A) Schematic structure of the PDGFRb and the ChiR. The ChiR contains the extracellular ligand-binding domain from the M-CSF receptor,
comprised of five immunoglobulin domains. The transmembrane and cytoplasmic domains of the ChiR are from the PDGFRb. K denotes the
split kinase domain of the receptors. The ChiR(WT) contains tyrosine (Y) at the indicated positions. In the ChiR(F5), these positions are changed
to phenylalanine (F). In the add-back ChiRs, tyrosines are restored at the indicated positions, while the remaining positions are phenylalanine.
(B) Schematic representation of the PDGFRb cytoplasmic domain, showing which signaling molecules bind to the phosphorylated tyrosines.
Phosphatidylinositol 39-kinase (PI3K) binds to tyrosines at positions 740 and 751, Ras GTPase±activating protein (RasGAP) binds at position
771, the SHP2 phosphatase binds at position 1009, and phospholipase Cg (PLCg) binds at position 1021. Mutation of these tyrosines to
phenylalanine prevents binding.
(C) Western blot of ChiR expression in NIH3T3 cells and ChiR-3T3 cells. Lanes contain 12.5 mg protein from total cell lysates of each cell line,
probed with an antibody to the extracellular domain of the M-CSF receptor. Cells expressing ChiRs with tyrosines at positions 740 and 751
have lower levels of receptor due to the role of these tyrosines in receptor turnover (Joly et al., 1994). Receptor types are labeled as in (A)
except for the kinase-dead (KD) receptors, which carry a lysine to arginine mutation at position 634 in the kinase domain of the PDGFRb
sequence.
(D) Mitogenic activity levels of NIH3T3 cells stimulated with 40 ng/ml PDGF and 40 ng/ml M-CSF, and of ChiR(WT)-3T3, ChiR(F5)-3T3, and
ChiR(KD)-3T3 cells stimulated with 40 ng/ml M-CSF. Before stimulation, confluent cells were brought to quiescence by incubating 24 hr in
0.5% bovine calf serum media. Mitogenesis was assayed by [3H]thymidine incorporation 16±18 hr after stimulation. Results are presented as
the percent of [3H]thymidine incorporated relative to NIH3T3 cells stimulated with 10% bovine calf serum.
phorylated and thus cannot bind and activate the signal- The ChiRs mimic the activity of endogenous PDGFRs
in standard assays. Stimulation of ChiR(WT)-3T3 cellsing molecules (Valius and Kazlauskas, 1993; Chung et
al., 1994; Franke et al., 1995; Valius et al., 1995; DeMali with saturating levels of M-CSF (40 ng/ml) resulted in
[3H]thymidine incorporation at 50% the level induced byet al., 1997; Montmayeur et al., 1997). ChiR(F5) con-
tains Y→F mutations at five positions: 740, 751, 771, 10% bovine calf serum, while cells not expressing the
ChiR and cells expressing ChiR(KD) each incorporated1009, and 1021 (Figures 1A and 1B; numbers correspond
to the amino acid position in the full-length human ,1% (Figure 1D). In comparison, NIH3T3 cells stimu-
lated with saturating levels of PDGF-BB (40 ng/ml) re-PDGFRb). These mutations block the receptor from
binding PI3K, RasGAP, SHP2, and PLCg. We also con- sulted in [3H]thymidine incorporation at 65% the level
induced by 10% bovine calf serum. Moreover, the genestructed a series of four ªadd-backº ChiRs that restore
the different tyrosines: ChiR(Y740, Y751) restores tyro- expression profiles of PDGF-BB-stimulated NIH3T3 cells
were nearly identical to the gene expression profilessines at positions 740 and 751, while ChiR(Y771),
ChiR(Y1009), and ChiR(Y1021) restore tyrosines at posi- of M-CSF-stimulated ChiR(WT)-3T3 cells (see below).
These results indicate that the ChiR(WT) appears totions 771, 1009, and 1021, respectively (Figures 1A and
1B). The ChiR(Y740, Y751), ChiR(Y771), ChiR(Y1009), faithfully reproduce the signaling activity of the endoge-
nous PDGFRs.and ChiR(Y1021) thus restore binding sites for PI3K,
RasGAP, SHP2, and PLCg, respectively. We also con-
structed a kinase-dead chimeric receptor, referred to Identification of Immediate Early Genes Induced
by the Wild-Type Chimeric Receptoras ChiR(KD), that carries a lysine to arginine mutation
at position 634 in the kinase domain that is known to We examined the IEG-inducing activity of the ChiR(WT).
Confluent, quiescent ChiR(WT)-3T3 cells were stimu-abolish kinase activity. The wild-type and mutant ChiR
genes were each used to generate NIH3T3 cell lines lated with saturating amounts of M-CSF (40 ng/ml) in
0.5% bovine calf serum media. Cells were harvested forexpressing the receptors (ChiR-3T3 cells) at approxi-
mately equal levels on their surfaces (Figure 1C). RNA at 20 min, 1 hr, 2 hr, and 4 hr after stimulation. All
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and references therein). Many of the others have been
reported as inducible by other growth factors, cytokines,
drugs, etc., or in other cell types. Conversely, of genes
reported to be PDGF- or serum-inducible IEGs in fibro-
blasts and represented on the oligonucleotide arrays,
77% (37/48) were found here as inducible by either
M-CSF alone (32/48) or by M-CSF 1 CHX (5/48). The
remaining 23% of the genes (11/48) were not found to
behave as IEGs in this experiment; no induction was
observed in five cases, induction was observed but fell
short of the stringent criteria in four cases, and induction
was observed but blocked by CHX in two cases.
Although the oligonucleotide arrays monitor less than
10% of the total number of mouse genes, the 66 IEGs
Figure 2. Transcript Monitoring by Hybridization to Oligonucleotide probably represent a much larger proportion of the total
Arrays number, because of extensive discovery efforts for this
Each gene represented on the array is detected by 20 matched class of genes. A full presentation of the observed gene
vertical pairs of 25-mer oligos. The top oligo in each pair is a perfect
expression levels exceeds the limitations of the printmatch (PM) 25-mer, and the bottom oligo has a single base mis-
format. Readers are encouraged to explore the data setmatch (MM) at the central position and serves as an internal control
available at our website (http://www.genome.wi.mit.for hybridization specificity. The intensity signals for each oligo are
shown here for the 20 oligo pairs that detect the gene encoding Zif/ edu/RTK/).
268. The gene shows background expression in unstimulated cells
(0 min), then shows peak expression after a 20 min stimulation,
Nearly All the Immediate Early Genes Are Inducedremains very high after 1 hr of stimulation, before dropping to much
by Chimeric Receptors Carrying Tyrosinelower levels after 2 hr of stimulation (see text for experiment design).
to Phenylalanine MutationsDifferent oligos hybridize at different intensities, depending on se-
quence composition. The average difference in hybridization inten- Having identified 66 ChiR(WT)-induced IEGs, we sought
sity between the PM and MM oligos (not the absolute intensity) is to assess the contribution of individual cytoplasmic tyro-
used to determine transcript level. The use of 20 pairs increases sine residues to the induction of these IEGs. To examine
the accuracy and reproducibility of the measurement.
the contribution of individual tyrosines, we analyzed the
activity of ChiRs carrying combinations of Y→F muta-
tions.
time points were completed in duplicate. In addition, We first analyzed the ChiR(F5) carrying Y→F muta-
cells were stimulated for 4 hr in the presence of 10 mg/ tions at sites 740, 751, 771, 1009, and 1021, which serve
ml cycloheximide (CHX) to determine which induced as binding sites for PI3K, RasGAP, SHP2, and PLCg.
genes behave as IEGs and which require protein synthe- Stimulation of ChiR(F5)-3T3 cells with M-CSF resulted
sis for their induction. in detectable induction of 64 of the 66 IEGs (Table 1).
The RNA was used for expression monitoring, using The average level of induction by ChiR(F5), however,
oligonucleotide arrays (Affymetrix, Inc.) containing de- was only 59% (630%) of that seen with ChiR(WT) (Fig-
tectors for 5938 gene and EST sequences (Figure 2). It ure 3A). The time course of induction by ChiR(F5) closely
should be noted that although changes in transcript tracked the time course of induction by ChiR(WT) (Figure
abundance (measured here) are not necessarily due to 3B). Only two genes, Bcl3 and Cish, showed markedly
transcriptional upregulation, previous experiments have increased induction by ChiR(F5) relative to ChiR(WT),
shown that transcriptional upregulation is by far the pre- suggesting that regulation of these genes differs from
ponderant mode of IEG induction by RTKs. that of the other IEGs (see below). If these two genes
To initially identify a set of clear IEGs, stringent criteria are excluded from the analysis, the remaining 64 genes
were set including at least 2-fold induction in both repli- were induced by ChiR(F5) to 55% (621%) of the
cates and at least 3-fold induction in one of the repli- ChiR(WT) level. Two other IEGs, KC and chop10, showed
cates at one time point (see Experimental Procedures). no induction at any time point in ChiR(F5)-3T3 cells,
To be classified as an IEG, genes had to be induced by although both were induced in ChiR(F5)-3T3 cells by
M-CSF both in the presence and absence of CHX. A M-CSF 1 CHX, suggesting that a low level of induction
total of 66 genes (1.1%) satisfied the criteria for being remained in ChiR(F5)-3T3 cells but was undetectable
IEGs (Table 1). An additional 43 genes (0.7%) were ob- without the transcript accumulation enhancement caused
served to be induced by M-CSF 1 CHX but were not by CHX. For the vast majority of IEGs, the residual activ-
strongly induced by M-CSF alone (Table 2). CHX is ity of ChiR(F5) is thus sufficient to cause some gene
known to promote transcript accumulation for many inductionÐshowing that none of the mutated tyrosines
IEGs. Control experiments using CHX alone were per- are absolutely essential for induction of at least 64 of
formed to ensure that induction by M-CSF 1 CHX ex- 66 of the IEGs, in the absence of CHX. Notably, ChiR(F5)-
ceeded any induction observed with CHX alone. 3T3 cells also retain a mitogenic response to M-CSF,
A review of the literature indicated that at least 48% although at only 40% the level of ChiR(WT)-3T3s (Fig-
of the ChiR-induced IEGs (32/66) have been previously ure 1D).
reported to be induced by PDGF or serum in mouse, We then sought to examine the influence of individual
rat, hamster, or human fibroblasts with immediate early tyrosine residues on IEG induction by studying the set
of add-back ChiRs in which individual binding sites arekinetics (see Rollins and Stiles, 1989; Herschman, 1991;
Table 1. Immediate Early Genes Induced by M-CSF Stimulation of ChiR(WT)-3T3 Cells
Fold Induction
Percentat Peak
GenBank Peak Time Induction Previously
Encoded Protein Accession No. Functional Classification Point ChiR(WT) ChiR(F5) by ChiR(F5) Reported
Zif/268 M22326 Transcriptional 20 min 72.1 43.5 60 Yes
c-Fos V00727 Transcriptional 20 min 54.0 26.5 49 Yes
Pip92 M59821 Cytoplasmic regulatory 20 min 36.3 12.6 35 Yes
Cyr61 M32490 Secreted 20 min 29.5 10.7 36 Yes
JunB J03236 Transcriptional 20 min 23.9 8.4 35 Yes
Krox20 X06746 Transcriptional 20 min 12.4 5.6 45 Yes
MKP1 X61940 Cytoplasmic regulatory 20 min 8.7 4.1 47 Yes
c-Jun J04115 Transcriptional 20 min 4.4 1.8 40 Yes
N10 X16995 Transcriptional 1 hr 53.9 18.7 35 Yes
TIS21 M64292 Cytoplasmic regulatory 1 hr 36.5 19.7 54 Yes
LRG21 U19118 Transcriptional 1 hr 35.4 12.5 35 Yes
PC4 J00424 Cytoplasmic regulatory 1 hr 10.5 2.8 27 Yes
Sim. PC4 W29669 Cytoplasmic regulatory 1 hr 10.4 3.2 31
KC J04596 Secreted 1 hr 10.1 1.0 10 Yes
MARC X70058 Secreted 1 hr 9.3 8.8 95 Yes
1kB U36277 Cytoplasmic regulatory 1 hr 7.2 1.0 14
EGRa Z36270 Transcriptional 1 hr 7.1 3.9 55
RhoB X99963 Cytoplasmic regulatory 1 hr 6.8 2.4 35 Yes
NAB2 U47543 Nuclear 1 hr 6.3 3.8 61 Yes
Chop10 X67083 Transcriptional 1 hr 6.2 1.0 17
MyD118 X54149 Nuclear 1 hr 6.1 3.2 53
eRF1 D87691 Cytoplasmic metabolic 1 hr 5.8 3.3 57
TIS11 M58691 Transcriptional 1 hr 5.7 3.0 53
Sim. DNAJ AA064330 Cytoplasmic metabolic 1 hr 4.5 3.7 82
C/EBP b X62600 Transcriptional 1 hr 4.3 4.5 104
Stra13 Y07836 Transcriptional 1 hr 4.3 2.5 57
Idb3 M60523 Transcriptional 1 hr 4.0 4.2 105 Yes
Sim. a-Actinin W71889 Cytoplasmic regulatory 1 hr 3.8 1.2 31
Cish D31943 Cytoplasmic regulatory 1 hr 3.6 6.4 179
Tissue factor M26071 Transmembrane 1 hr 3.2 1.5 47 Yes
IRF1 M21065 Transcriptional 1 hr 3.2 0.9 29 Yes
NF-kB p65 M61909 Transcriptional 1 hr 3.0 2.2 74
Cox2 M88242 Cytoplasmic regulatory 2 hr 109.4 40.7 37 Yes
PAI1 M33960 Secreted 2 hr 33.4 14.8 44 Yes
Thbs1 M87276 Matrix 2 hr 32.8 21.4 65 Yes
HB-EGF U39192 Secreted 2 hr 26.4 19.5 74 Yes
VEGF M95200 Secreted 2 hr 24.7 14.0 57 Yes
Epiregulin D30782 Secreted 2 hr 22.8 13.4 59
Gly96 X67644 Transmembrane 2 hr 13.0 7.8 60 Yes
CD44 X66084 Transmembrane 2 hr 12.4 7.0 56
IL11 U03421 Secreted 2 hr 12.1 6.2 52
a5 Integrin X79003 Transmembrane 2 hr 11.4 5.9 52
Sim. TSG6 AA051341 Secreted 2 hr 10.0 4.4 44
Tx01 Z31326 Unknown 2 hr 9.4 5.2 56
TDAG51 U44088 Cytoplasmic regulatory 2 hr 8.7 5.5 63
MAPkk3b D87115 Cytoplasmic regulatory 2 hr 8.7 5.1 59
Tenascin X56304 Matrix 2 hr 8.0 6.0 75 Yes
Sim. a5 integrin AA002759 Transmembrane 2 hr 7.4 4.1 55
MAPKAPK2 X76850 Cytoplasmic regulatory 2 hr 6.5 3.5 54
TIS11D M58564 Transcriptional 2 hr 5.9 5.8 98
Sim. CHX1 AA013648 Cytoplasmic regulatory 2 hr 5.7 3.6 62
CTGF M70641 Secreted 2 hr 4.9 2.1 43 Yes
MyD116 X51829 Cytoplasmic regulatory 2 hr 4.9 1.4 29
c-Myc X01023 Transcriptional 2 hr 4.8 2.5 52 Yes
Sim. NF-kB p100 AA013831 Transcriptional 2 hr 4.2 3.2 77
Bcl3 M90397 Nuclear 2 hr 4.2 7.6 180
ARF2 D87899 Cytoplasmic metabolic 2 hr 4.0 3.5 88
GT1 M23384 Transmembrane 2 hr 4.0 3.4 85 Yes
Fra1 U34245 Transcriptional 2 hr 3.8 2.6 69 Yes
MyD88 X51397 Cytoplasmic regulatory 2 hr 3.8 2.5 66
Mdm2 X58876 Cytoplasmic regulatory 2 hr 3.6 2.1 57
Sim. PSF AA035984 Nuclear 2 hr 3.3 2.7 81
SNK M96163 Cytoplasmic regulatory 2 hr 3.1 1.5 47 Yes
JE M19681 Secreted 4 hr 4.2 3.3 79 Yes
TIMP1 M28312 Secreted 4 hr 3.9 2.4 62
LIX U27267 Secreted 4 hr 3.4 1.4 40
IEGs induced by 40 ng/ml M-CSF stimulation of quiescent ChiR(WT)-3T3 cells, listed by time of peak observed induction. ESTs are named
according to gene to which they show greatest sequence similarity. The listed accession number is the GenBank entry from which the oligo
probe sequences were drawn. A gene is classified as previously reported if it has been reported to be PDGF or serum inducible in fibroblasts;
see Rollins and Stiles, 1989, and Herschman, 1991, and references therein. Data are for a single experiment.
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Removal of an Additional Tyrosine Has FurtherTable 2. Additional Immediate Early Genes Induced by M-CSF
Broad Effects on IEG Inductionand CHX Stimulation of ChiR(WT)-3T3 Cells
The fact that induction of most IEGs is not abolished in
GenBank ChiR(F5) shows that the tyrosine resides are not abso-
Encoded Protein Accession No. Functional Classification
lutely required, and it also suggests that the associated
Apg1 D85904 Cytoplasmic metabolic signaling pathways activate not independent modules
Cytochrome p450 D17571 Cytoplasmic metabolic but broadly overlapping sets of IEGs.
Sim. g Enolase W48081 Cytoplasmic metabolic
We sought to further examine IEG induction by remov-Sim. Arginyl-tRNA AA104940 Cytoplasmic metabolic
ing an additional tyrosine residue. A ChiR(F6) was con-synthetase
structed by making an additional Y→F mutation in posi-BTG3 Z72000 Cytoplasmic regulatory
Sim. EPS15 W40735 Cytoplasmic regulatory tion 716 in the PDGFRb cytoplasmic domain of ChiR(F5).
Sim. Ras-related AA023591 Cytoplasmic regulatory This tyrosine is reported to bind the Grb2 adaptor protein
G protein W64628 Cytoplasmic regulatory (Arvidsson et al., 1994), which binds the Ras-activating
g subunit II protein SOS and thereby helps mediate activation of
p130Cas U28151 Cytoplasmic regulatory
Ras. We tested the ability of M-CSF to induce IEG ex-PTP M81477 Cytoplasmic regulatory
pression in ChiR(F6)-3T3 cells at 1 hr and 2 hr afterSTAM U43900 Cytoplasmic regulatory
M-CSF stimulation. These are the time points of peakTRAF1 L35302 Cytoplasmic regulatory
MnSOD L35528 Mitochondrial induction by ChiR(WT) for 55 of the 66 IEGs. Of these
Sim. SPR75 AA168900 Nuclear 55 genes, 37 are induced to high levels ($3-fold) by
GADD45 L28177 Nuclear ChiR(F5), while most of the remainder are induced to
JkRSbp X17459 Nuclear
lower levels.RNA helicase U46690 Nuclear
To assess the effects of ChiR(F6), we focused on theTOPO I D10061 Nuclear
37 IEGs induced to high levels by ChiR(F5) (given theAdrenomedullin U77630 Secreted
FGF7 Z22703 Secreted limitations on accurately measuring changes in genes
IP10 M86829 Secreted with low levels of induction). The great majority showed
M-CSF M21952 Secreted lower induction by ChiR(F6) relative to ChiR(F5) (Table
NGF b V00836 Secreted 3). About 59% were induced to levels at least 1.5-foldPTX3 X83601 Secreted
lower by ChiR(F6) than by ChiR(F5). The great majorityA20 U19463 Transcription factor
of these genes were also induced to 1.5-fold lower levelsDermo1 U36384 Transcription factor
Sim. EKLF AA168184 Transcription factor by ChiR(F5) than by ChiR(WT), indicating quantitative
Sim. RPD3 W75918 Transcription factor contributions from both Y716 and at least one of the
HES1 D16464 Transcription factor tyrosines mutated in ChiR(F5). Together, these results
Id M31885 Transcription factor suggest that the sixth tyrosine also affects a substantial
IRF3 U75839 Transcription factor
proportion of the IEGs.NAB1 U47008 Transcription factor
Interestingly, the Bcl3 and Cish genes were moreNF-kB M57999 Transcription factor
highly induced by ChiR(F6) than by ChiR(F5); theseNF-kB p105 L28117 Transcription factor
Nrf2 U20532 Transcription factor genes are notable for being more highly induced by
RelB M83380 Transcription factor ChiR(F5) than by ChiR(WT). This may indicate that induc-
Sna M95604 Transcription factor tion of Bcl3 and Cish is mediated by a mechanism dis-
Fas M83649 Transmembrane
tinct from that of the other IEGs, and that the inducingICAM1 M31585 Transmembrane
activity for these two genes increases as signaling byPTP35 X74438 Transmembrane
the ChiR decreases.PVR D26107 Transmembrane
Stomatin U17297 Transmembrane
B94 L24118 Unknown No Evidence for Cross-Activation of Endogenous
Receptors by Chimeric ReceptorsESTs are named according to gene to which they show greatest
We performed a number of control experiments to showsequence similarity. The listed accession number is the GenBank
entry from which the oligo probe sequences were drawn. that the induction of the 66 IEGs is due to activation
of the ChiRs themselves, rather than through indirect
causes such as the effect of M-CSF on fibroblasts or
heterodimerization of ChiRs with endogenous RTKs.
To examine the effect of M-CSF on fibroblasts, we
restored to ChiR(F5). Unfortunately, expression monitor- stimulated NIH3T3 cells (not expressing ChiRs) with
ing is not sufficiently sensitive to accurately discriminate M-CSF and examined their mitogenic and gene expres-
precise levels of gene expression within the narrow sion responses. M-CSF stimulation of NIH3T3 cells has
range of the roughly 2-fold change in gene expression no mitogenic effect (Figure 1), does not cause MAP
between ChiR(F5) and ChiR(WT). Our data thus cannot kinase activation nor PDGFR phosphorylation (Figure
rule out differential contributions of particular tyrosines 4), and gene expression levels following M-CSF stimula-
to the particular IEGs, but the data at least indicate that tion of NIH3T3 cells were within the range observed for
none are essential for 64 of the 66 IEGs. For the two IEGs unstimulated cells (see http://www.genome.wi.mit.edu/
that were not induced by ChiR(F5), only ChiR(Y1021) RTK/). These data indicate that endogenous RTKs are
showed reproducible induction of either gene. ChiR not activated by M-CSF.
(Y1021) induction of KC was at one-third of ChiR(WT) To exclude the possibility that the ChiRs act by hetero-
levels, while ChiR(Y1021) induction of chop10 was com- dimerizing with an endogenous RTK upon ligand bind-
parable to ChiR(WT) induction. As discussed below, ing, we analyzed the behavior of the kinase-dead chi-
mera ChiR(KD). Kinase-dead PDGFRs do not behave asChiR(Y771) exhibited a unique gene-inducing activity.
Signaling Pathways Induce Broadly Overlapping Genes
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Figure 3. Induction of Immediate Early
Genes following ChiR(WT) and ChiR(F5) Acti-
vation
Confluent ChiR(WT)-3T3 and ChiR(F5)-3T3
cells were brought to quiescence by culturing
in 0.5% bovine calf serum media for 48 hr.
Cells were then stimulated with 40 ng/ml
M-CSF for 20 min, 1 hr, 2 hr, and 4 hr to
activate the ChiRs.
(A) Semilogarithmic scatter plot of the ratio
of IEG induction by ChiR(F5) over induction
by ChiR(WT), plotted relative to induction by
ChiR(WT). All 66 IEGs are plotted using the
data from the time point at which each gene
shows peak induction by ChiR(WT), as shown
in Table 1. The dotted line indicates a
ChiR(F5)/ChiR(WT) induction ratio of 0.5. The
two outlying genes, at a ratio of approxi-
mately 1.8, and Bcl3 and Cish.
(B) Induction profiles for six highly induced
genes over the course of the experiment. For
most IEGs, the time course of induction fol-
lowing activation of ChiR(WT) (squares) and
ChiR(F5) (circles) is the same, with induction
by ChiR(F5) significantly lower than induction
by ChiR(WT). Data are expressed as fold in-
duction relative to unstimulated cells (0 min).
dominant inhibitory receptors (as do truncated RTKs that the kinase-dead receptor does not interfere with
endogenous PDGFRbs. The inactivity of ChiR(KD) thusthat lack a cytoplasmic domain), but rather they behave
as passive dimerization partners that can be phosphory- indicates that the activity of the other ChiRs is not due
to heterodimerization with other endogenous RTKs.lated but cannot phosphorylate their dimerization part-
ner (Ueno et al., 1993). Such heterodimers are active
and can engage in signaling. For example, HepG2 cells A Group of Genes Normally Associated
with Interferon Induction Show anexpress very low levels of PDGFRa, and PDGF-BB stim-
ulation of HepG2 cells does not cause detectable signal- Unexpected Pattern of Inducibility
Although we found scant evidence that individual tyro-ing activity. However, PDGF-BB stimulation of HepG2
cells expressing kinase-dead PDGFRbs causes sub- sines are required to activate distinct modules of IEGs
normally induced by the wild-type signaling domain, westantial and easily detectable activation of the RAF1,
MEK1, and p42 MAP kinases through the formation of did observe that one of the add-back ChiRs induced an
independent module of genes not normally induced bya/b heterodimers (Vaillancourt et al., 1996). The use of
ChiR(KD) thus provides a way to test whether heterodi- the wild-type signaling domain.
Surprisingly, M-CSF stimulation of ChiR(Y771)-3T3merization is occurring with any endogenous receptor.
M-CSF stimulation of ChiR(KD)-3T3 cells does not cells caused induction of 15 genes above the levels
observed in ChiR(WT)-3T3 cells (Figure 5A). While noneinduce mitogenesis (Figure 1), and observed gene ex-
pression levels were within the range exhibited by of these genes met the criteria for M-CSF-inducible IEGs
in ChiR(WT)-3T3 cells, seven met the criteria in ChiR(Y771)-unstimulated cells. In addition, M-CSF stimulation of
ChiR(KD)-3T3 cells does not cause MAP kinase activa- 3T3 cells. The remaining eight genes met the criteria of
3-fold induction in the presence of CHX. For all genes,tion, as would be expected if ChiR(KD) were being phos-
phorylated by endogenous RTKs (Figure 4; Vaillancourt the induction observed in ChiR(Y771)-3T3 cells was at
least 3-fold greater than the levels observed in ChiRet al., 1996). Moreover, costimulation of ChiR(KD)-3T3
cells with M-CSF and PDGF-BB resulted in mitogenic (WT)-3T3 cells, either with or without CHX. Northern
analysis confirmed the higher levels of induction inactivity levels equivalent to PDGF-BB stimulation alone
(99.2% 6 3.4% vs. 100% 6 2.7%, n 5 6), suggesting ChiR(Y771)-3T3 cells relative to ChiR(WT)-3T3 cells for
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Table 3. Immediate Early Genes Induction by 40 ng/ml M-CSF Stimulation of ChiR(F5)-3T3 Cells and ChiR(F6)-3T3 Cells
Fold Induction at Peak
GenBank Peak Percent Induction
Encoded Protein Accession No. Functional Classification Time Point ChiR(F5) ChiR(F6) by ChiR(F6)
TIS21 M64292 Cytoplasmic regulatory 1 hr 19.7 24.8 126
N10 X16995 Transcriptional 1 hr 18.7 21.8 116
LRG21 U19118 Transcriptional 1 hr 12.5 8.3 66
MARC X70058 Secreted 1 hr 8.8 8.3 94
Cish D31943 Cytoplasmic regulatory 1 hr 6.4 8.6 134
C/EBP b X62600 Transcriptional 1 hr 4.5 5.7 128
Id3 M60523 Transcriptional 1 hr 4.2 1.7 40
EGRa Z36270 Transcriptional 1 hr 3.9 2.3 58
NAB2 U47543 Nuclear 1 hr 3.8 4.3 112
Sim. DNAJ AA064330 Cytoplasmic metabolic 1 hr 3.7 0.6 16
eRF1 D87691 Cytoplasmic metabolic 1 hr 3.3 1.3 40
Sim. PC4 W29669 Cytoplasmic regulatory 1 hr 3.2 1.1 34
MyD118 X54149 Nuclear 1 hr 3.2 3.3 104
TIS11 M58691 Transcriptional 1 hr 3.0 7.9 265
Cox2 M88242 Cytoplasmic regulatory 2 hr 40.7 11.3 28
Thbs1 M87276 Matrix 2 hr 21.4 8.5 40
HB-EGF U39192 Secreted 2 hr 19.5 2.4 12
PAI1 M33960 Secreted 2 hr 14.8 7.7 52
VEGF M95200 Secreted 2 hr 14.0 3.1 22
Epiregulin D30782 Secreted 2 hr 13.4 5.0 37
Gly96 X67644 Transmembrane 2 hr 7.8 9.1 116
Bcl3 M90397 Nuclear 2 hr 7.6 11.2 148
CD44 X66084 Transmembrane 2 hr 7.0 1.0 14
IL11 U03421 Secreted 2 hr 6.2 1.0 16
Tenascin X56304 Matrix 2 hr 6.0 1.4 23
a5 integrin X79003 Transmembrane 2 hr 5.9 2.3 38
TIS11D M58564 Transcriptional 2 hr 5.8 3.6 62
TDAG51 U44088 Cytoplasmic regulatory 2 hr 5.5 5.0 90
Tx01 Z31326 Unknown 2 hr 5.2 4.2 79
MAPkk3b D87115 Cytoplasmic regulatory 2 hr 5.1 1.0 20
Sim. TSG6 AA051341 Secreted 2 hr 4.4 1.3 28
Sim. a5 integrin AA002759 Transmembrane 2 hr 4.1 2.9 70
Sim. CHX1 AA013648 Cytoplasmic regulatory 2 hr 3.6 1.6 46
ARF2 D87899 Cytoplasmic metabolic 2 hr 3.5 2.0 58
MAPKAPK2 X76850 Cytoplasmic regulatory 2 hr 3.5 1.0 28
GT1 M23384 Transmembrane 2 hr 3.4 2.4 72
Sim. NF-kB p100 AA013831 Transcriptional 2 hr 3.2 4.0 125
10 of 10 genes tested (Figure 5B and data not shown). Since the IFNg signal is largely carried by STAT1,
STAT1 activation by the ChiR(Y771) may be responsibleThe induction of these 15 genes was reproducibly ob-
served in two independently derived ChiR(Y771)-3T3 for the induction of this gene module. STAT1 is activated
(phosphorylated and translocated to the nucleus) follow-cell populations.
The fact that these genes are strongly induced by ing PDGFRb activation, but STAT1-regulated genes are
not normally observed to be induced (Silvennoinen etChiR(Y771) but not ChiR(WT) suggests that they can be
induced by a signaling pathway activated by binding to al., 1993; Yamamoto et al., 1996). The phosphorylated
Y771 site is known to bind the RasGAP protein, sug-Y771, but that signaling involving one or more of Y740,
Y751, Y1009, and Y1021 normally serves to repress their gesting that attenuation of Ras signaling may release
this gene module from inhibition, revealing the STAT1-induction.
Interestingly, many of the ChiR(Y771)-inducible genes mediated transcriptional induction. It is of note that neg-
ative interactions between the Ras pathway and STAT3are also known to be inducible by interferons, particu-
larly interferon g (IFNg; Boehm et al., 1997). This common activity, which is also activated by the PDGFRb, have
been documented (Chung et al., 1997; Jain et al., 1997).property supports the notion that these genes are part
of a coregulated module. Of particular note, ChiR(Y771) These interactions may be an example of interacting
positive and negative signals initiated by the PDGFRbinduces the gene encoding MIG (monokine induced by
gamma interferon), a gene induced by IFNg but not by (Heldin, 1997).
We verified that most of these 15 ChiR(Y771)-induc-IFNa/b or other treatments (Wright and Farber, 1991).
ChiR(Y771) also induces the genes encoding the STAT1 ible genes are in fact induced by IFNg in NIH3T3 cells.
After a 2 hr stimulation with 1 ng/ml IFNg, 13 of the 15and ISGF3g proteins, which in addition to being induced
by IFNg also mediate the IFNg transcriptional response genes showed at least some detectable gene induction;
only the genes encoding Follistatin and LKLF did not(Darnell, 1997). The similarities between the ChiR(Y771)
and IFNg transcriptional responses suggest that the show induction (data not shown). Indeed, the three
genes showing the highest level of induction by IFNgphysiological mechanism of gene induction by these
two inducers may be the same. are all inducible by M-CSF in ChiR(Y771)-3T3 cells: the
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(WT)-3T3 cells, although there were some quantitative
differences in the levels of induction observed. This re-
sult suggests that the PDGFRs and FGFR1 allow fibro-
blasts to trigger largely the same program of gene ex-
pression in response to different extracellular ligands.
In contrast, EGF stimulation of NIH3T3 cells resulted
in a similar, but clearly distinct, transcriptional response.
First, EGFR activation induced many of the same genes
as PDGFR and FGFR1 activation, but the level of induc-
tion was lower. For example, the genes encoding the
transcription factors Zif/268 and N10 were induced 20-
fold by EGF (relative to unstimulated cells), compared
to approximately 100-fold with PDGF-BB, FGF1, and
FGF4. Second, some genes induced by PDGF-BB and
FGF1/FGF4 showed no induction after EGF stimulation.
For example, EGF failed to induce expression of the
genes encoding the transcription factors c-Fos and
LRG21, each of which showed 35- to 100-fold induction
with PDGF-BB, FGF1, and FGF4. EGF did not induce
any new IEGs. Rather the EGF response was a subset
of the PDGF and FGF response. These observations areFigure 4. MAP Kinase Activation by PDGFRs and ChiRs
likely related to the reduced ability of EGF to stimulate(A) Each lane contains protein from total cell lysates of 1 3 105 cells
mitogenesis in NIH3T3 cells and may reflect the reducedstimulated with the indicated growth factors for 10 min. Prior to
abundance of EGFRs on the fibroblast surface com-stimulation cells were brought to quiescence by culturing in 0.5%
bovine calf serum media for 48 hr. PDGF-BB stimulation of NIH3T3 pared to the PDGFRs and FGFRs. It is possible that
cells, even at low levels, results in strong MAP kinase activation, as increasing the number of EGFRs on the cell surface
visualized with an antibody to the phosphorylated MAP kinase p44/ would cause the EGF response to more closely resemble
42 proteins. ChiR(WT)-3T3 cells stimulated with M-CSF also show
the PDGF and FGF response.strong MAP kinase activation. Activation by the ChiR(F5) is less
strong. ChiR(KD) does not cause MAP kinase activation.
Discussion(B) Western blot of total lysates from cells, as in (A), stimulated for
10 min with 40 ng/ml PDGF-BB (NIH3T3 cells) or 40 ng/ml M-CSF
(ChiR-3T3 cells) and probed with an anti-phosphotyrosine antibody. RTK activation triggers a panoply of signaling pathways
Phosphorylated PDGFRs run as a smear of higher molecular weight resulting in various cellular responses, including induc-
than phosphorylated ChiRs. M-CSF stimulation of ChiR-3T3 cells tion of IEGs. What is the purpose of ramifying a single
reveals phosphorylation of a single tight band of lower molecular
extracellular message into such a diversity of intracellu-weight.
lar signals? What are the mechanistic interactions
among the signaling pathways? We sought to explore
these issues with respect to IEG induction by usinggenes encoding LRG47, GBP, and Mg21. These are all
expression monitoring to take a global view of transcrip-guanine nucleotide±binding proteins whose biological
tion induced by wild-type and mutant receptors.
roles are currently unknown.
The wild-type ChiR was found to induce a total of
66 IEGs out of about 6000 genes monitored. We then
The PDGFRs and FGFR1 Have Nearly expected to dissect the IEGs into subsets that were
Indistinguishable Patterns of Immediate dependent on particular signaling pathways by studying
Early Gene Induction mutant receptors lacking some or all of the five critical
Fibroblasts normally express multiple RTKs, including tyrosines implicated in activation of the Ras, PLCg, PI3K,
PDGFRa and PDGFRb, fibroblast growth factor receptor and SHP2-activated pathways. This expectation was
1 (FGFR1), and the epidermal growth factor receptor based in part on previous suggestions that some IEGs
(EGFR). Though these receptors are activated by differ- may be primarily regulated by particular signaling path-
ent ligands, they are reported to act through many of the ways (Barone and Courtneidge, 1995; Roche et al., 1996;
same signaling pathways. It has not been clear whether Montmayeur et al., 1997).
these different receptors act by inducing distinct tran- Instead, we have unambiguously shown that none of
scriptional responses, or whether they act by allowing the five key tyrosines studied are absolutely essential
fibroblasts to respond similarly to distinct extracellular for induction of the vast majority of the IEGs; at least
signals. 64 of the 66 IEGs were still induced at least partially by
We sought to examine this question by measuring the ChiR(F5) mutant receptor. Nonetheless, the IEGs
gene expression in NIH3T3 cells stimulated with saturat- depend to some extent on the set of five tyrosines inas-
ing levels of PDGF-BB, FGF1, FGF4, and EGF for 1 hr. much as their elimination quantitatively reduces the level
(Both FGF1 and FGF4 are ligands for FGFR1.) We ob- of induction.
served nearly indistinguishable induction of IEG expres- The lack of absolute dependence on the key tyrosines
sion following PDGF-BB, FGF1, and FGF4 stimulation implies a similar lack of absolute dependence on the
of NIH3T3 cells (Figure 6 and http://www.genome.wi. associated signaling pathways, inasmuch as studies
mit.edu/RTK/). These treatments induced essentially the have shown that the tyrosines are essential for the ac-
tivation of the pathways in multiple cell types, includ-same set of genes as did M-CSF stimulation of ChiR
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Figure 5. Genes Induced as IEGs in
ChiR(Y771)-3T3 Cells but Not in ChiR(WT)-
3T3 Cells
(A) Fifteen genes are induced to higher levels
in ChiR(Y771)-3T3 cells relative to ChiR(WT)-
3T3 cells. Data are for 4 hr after 40 ng/ml
M-CSF stimulation. Prior to stimulation cells
were brought to quiescence by culturing in
0.5% bovine calf serum media for 48 hr.
Genes with an asterisk meet the criteria for
being IEGs in ChiR(Y771)-3T3 cells. For Mg21
and PNBP, this table lists ChiR(Y771)-3T3 in-
duction levels as less than ChiR(WT)-3T3 in-
duction because data from only a single ex-
periment are included in the table. N.D., no
data.
(B) Each lane contains 10 mg of total RNA
from ChiR(WT)-3T3 or ChiR(Y771)-3T3 cells.
Total RNA was prepared from cells as in (A)
before stimulation (0 hr), after 1 hr and 2 hr
stimulation with 40 ng/ml M-CSF, and after 4
hr stimulation with 40 ng/ml M-CSF and 10
mg/ml CHX. Following electrophoresis and
blotting, filters were probed with sequences
from the genes encoding LRG47, GARG16,
ISG15, and GAPDH.
ing human HepG2 cells (Valius and Kazlauskas, 1993; the wild-type signaling domain, our data unexpectedly
revealed that one of the add-back receptors indepen-Chung et al., 1994), A431 cells (Valius et al., 1995; Mont-
mayeur et al., 1997), canine TRMP cells (Franke et al., dently induces a distinct set of genes not normally in-
duced by the PDGFRb. Specifically, the ChiR(Y771)1995), and murine Ph 3T3-like cells (DeMali et al., 1997).
Instead, the pathways appear to make quantitative con- showed an unanticipated gene-inducing activity not ob-
served with the ChiR(WT), resulting in the induction oftributions to IEG induction. Elimination of a sixth tyrosine
affected a substantial proportion of those genes in- 15 additional genes. Most of these ChiR(Y771)-induced
genes are also inducible by IFNg. These results suggestduced to high levels by ChiR(F5), again consistent with
a picture of largely quantitative rather than qualitative that signaling pathways dependent on Y771 can induce
a module of coregulated genes, but that signaling path-roles for specific tyrosines and specific pathways.
Several models could explain the observations. First, ways involving one or more of Y740, Y751, Y1009, and
Y1021 repress this gene induction. As discussed above,each pathway may reach the nucleus as a distinguish-
able input (Montmayeur et al., 1997) and activate IEG this induction may be mediated by STAT1 and is perhaps
normally repressed by Ras signaling. Prior work hasinduction through particular promoter elements that are
pathway specific. The pathways may thus converge at demonstrated that Ras signaling negatively regulates
STAT3 activity (Chung et al., 1997; Jain et al., 1997), butthe promoter and cooperate to induce transcription.
Some limited data regarding IEG promoter structure is such an interaction has not been demonstrated with
STAT1 (David et al., 1995; Zhu et al., 1997). This suggestsconsistent with this view (Price et al., 1996). Second, the
pathways may engage in extensive cross-talk, perhaps that the hypothesized interaction may be indirect, that
the tyrosine at position 771 may regulate STAT1 accessmediated by adaptor proteins that are downstream of
the initial events in receptor signaling (Pawson and to the receptor, or that the interaction may be mediated
by other activities of the RasGAP protein. In any case, itScott, 1997). Third, multiple receptor-activated path-
ways may converge and funnel through a small number is interesting to speculate that the ChiR(Y771) response
may reflect how fibroblasts integrate and alter their be-of signaling intermediates, such as the Ras-MAPK path-
way, that globally regulate IEG induction. These alterna- havior in response to contradictory inputs that are both
growth activating (via the PDGFR) and growth sup-tives are not exclusive, and each may contribute to the
observed broadly overlapping effects on IEG induction. pressing (via downregulation of other signaling path-
ways). In response to these contradictory inputs, fibro-Although there was little evidence that specific path-
ways induce specific subsets of IEGs in the case of blasts may exhibit a modified proinflammatory response
Signaling Pathways Induce Broadly Overlapping Genes
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Figure 6. Induction of Immediate Early Genes
by PDGF-BB, FGF1, FGF4, and EGF Stimula-
tion of NIH3T3 Cells
Expression levels for 22 IEGs after 1 hr growth
factor stimulation, as measured by oligo array
hybridization and expressed as fold induction
relative to unstimulated cells. These 22 genes
include all the PDGF-BB-inducible IEGs ex-
pressed greater than 10-fold in NIH3T3 cells.
Values are for stimulation by 40 ng/ml PDGF-
BB (white bars), 10 ng/ml FGF1 plus 10 mg/
ml heparin (gray bars), 10 ng/ml FGF4 (striped
bars), and 25 ng/ml EGF (black bars). Prior to
stimulation cells were brought to quiescence
by culturing in 0.5% bovine calf serum media
for 48 hr.
by inducing an additional gene module like that induced In any case, our studies offer an experimental para-
digm for approaching these questions. Clearly, it will beby IFNg.
Overall, the data suggest that signaling pathways initi- important to study additional Y→F mutations in PDGFR,
a wider range of ligand levels, other receptors besideated by RTKs have broadly overlapping effects on IEG
induction. Nonetheless, the potential for independent PDGFR, and other cell types.
What might be the purpose of ramifying an extracellu-induction of IEG modules is revealed by ChiR(Y771).
The present study has many limitations, and it would lar signal into multiple intracellular pathways with com-
pletely or largely overlapping targets? A receptor thatbe premature to draw general conclusions about all
RTK-initiated signaling. First, we have focused only on signals through a number of independent pathways
could readily send qualitatively different messages, ifa single RTK (PDGFR) and a single cell type (NIH3T3
cells). It is possible that RTK-activated signaling path- these pathways were also regulated by other cellular
factors. In contrast, a receptor that signals throughways act more independently in other cellular settings.
Second, we have studied a situation in which the recep- largely convergent or interacting pathways would tend
to send a single type of message that could be modu-tor (both the native PDGFRs and our ChiRs) and the
ligand are present in abundance. Although our results lated quantitatively.
RTK signaling would appear to more closely resemblerule out an absolute dependence of IEGs on Y740, Y751,
Y771, Y1009, or Y1021, it is conceivable that in our the latter situation of quantitative control. The multiple
pathways may primarily function to integrate informationsetting the signaling pathways normally activated by
these tyrosine residues can be cross-activated to a low about different aspects of cell state into an overall gen-
eral activation level for IEG induction (to which each IEGbut relevant level by the remaining cytoplasmic tyro-
sines in ChiR(F5), which normally activate other path- could respond in a gene-specific fashion). The multiple
pathways could also confer robustness, so that the re-ways. Third, we have only studied the IEGs among a
set of about 6,000 genes. It is possible that additional sponse is not dependent on any single pathway and
thus can be triggered under a variety of circumstances.IEGs exist that act as an independent module down-
stream of a particular pathway or set of pathways. A mathematical analogy could be drawn to a dense
rather than sparse matrix in which most input variablesFourth, we have only examined the effects of RTK signal-
ing on immediate early transcriptional induction. Differ- affect most output variables. More loosely, a biological
analogy might be drawn to the integrative function ofential effects of signaling pathways on other cellular
componentsÐfor example, the cytoskeletonÐare not neurons: the signaling pathways might play the role of
individual dendrites that collect diverse inputs and inte-considered here. Such effects may have important cel-
lular consequences, including transcriptional conse- grate them at the axon hillock into a single firing rate,
which in turn results in differential effects on distinctquences that would not be evident when only IEGs are
considered. There are substantial and long-acting tran- postsynaptic cells. Of course, we do not mean to imply
that the RTK-activated pathways necessarily integratescriptional changes in fibroblasts following RTK activa-
tion that do not meet the IEG criteria (e.g., see Iyer et into a single unitary induction signal. The situation is
surely more complex.al., 1999). It is also known that there are differences
in the ability of certain receptor tyrosines to activate It should be remarked that the precise quantitative
level of RTK-induced IEG transcription can have crucialnontranscriptionally mediated processes, such as recep-
tor turnover (Joly et al., 1994) or chemotaxis (Kundra et effects in determining cellular response. For example,
PC12 cells either differentiate or reenter the cell cycleal., 1994). Fifth, our results do not address the nature of
the interaction between signaling pathways in contributing according to RTK activation levels (Dikic et al., 1994;
Taverse et al., 1994). Similarly, morphogen gradientsto IEG induction. As discussed above, the pathways may
induce overlapping sets of IEGs through convergence function during embryonic development by inducing
distinct responses to different quantitative levels of aupon complex promoters, convergence upon common
signaling pathways, or cross-talk among pathways. signal, for example in defining both the Drosophila and
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expression vector (Miller and Rosman, 1989), sequence verified, andXenopus body plans (St. Johnston and NuÈ sslein-Vol-
transfected into the 293T packaging cell line as described (DeMalihard, 1992; Sasai and De Robertis, 1997).
et al., 1997). Forty-eight hours after transfection, retroviral superna-The second intriguing observation from this study is
tants were added to NIH3T3 cells (CRL-1658; ATCC, Rockville, MD)
that PDGFR activation (by PDGF-BB) and FGFR activa- as described (DeMali et al., 1997). After selection with 0.8 mg/ml
tion (by FGF1 or FGF4) in NIH3T3 cells results in essen- G418 (GIBCO Life Technologies, Gaithersburg, MD), cells were live-
labeled with an antibody to the extracellular domain of the ChiRtially indistinguishable transcriptional responses 1 hr
(2-4A5, Santa Cruz Biotechnology, Santa Cruz, CA) and a fluores-after activation. These two RTKs have different ligand
cein-conjugated secondary antibody (Santa Cruz), and ChiR-3T3binding specificities but may otherwise be functionally
cells were isolated by FACS.interchangeable. Several other cases are known in
which one receptor can be replaced by a related recep-
Mitogenesis Experiments
tor. In the Drosophila eye, the Sevenless RTK can be [3H]thymidine incorporation assays were performed by plating 5 3
substituted by the Drosophila EGF receptor (Freeman, 105 cells per well in gelatinized 24-well plates in DMEM 1 0.5%
bovine calf serum. After 24 hr, cells were rinsed with media and1996), while in erythroid development, the Epo receptor
stimulated with growth factors. [3H]thymidine was added to the me-can be substituted by the Prolactin receptor (Socolov-
dia 16 hr after stimulation, and 2 hr later cells were rinsed twicesky et al., 1997). Taken together with the present study,
with ice-cold PBS, incubated in 5% trichloroacetic acid for 20 minsuch instances suggest that RTKs have unique ligand
at 48C, then rinsed twice with 70% ethanol and solubilized in 1 ml
specificities but may typically transmit a ªgenericº sig- 0.1 M NaOH, 1% SDS, 2% Na2CO3. [3H]thymidine incorporation was
nal, at least with respect to IEG induction. determined by scintillation counting.
The notion that diverse RTKs may transmit a generic
signal emphasizes that cellular responses to a ligand Western Blots
MAP kinase activation was measured by plating 1 3 106 cells permay depend less on the identity of the ligand than on
well in a gelatinized 6-well plate in DMEM 1 0.5% bovine calf serum.the differentiation state of the cell.
After 48 hr, cells were rinsed with media and stimulated with growthEGFR activation induces a set of genes that is a subset
factors for 10 min. Cells were then rinsed with ice-cold PBS and
of those induced by PDGFR and FGFR activation. This lysed into sample buffer. Proteins were separated by SDS±PAGE
may be attributable to the fact that EGFR is present in and Western blotted using standard techniques, and they were
probed with both phospho-specific and general p44/42 MAP kinaseNIH3T3 cells at lower levels than the other receptors,
antibodies (New England Biolabs, Beverly, MA) or anti-phosphotyro-resulting in a lower level of the generic RTK signal and
sine antibodies (Santa Cruz Biotech.). Western blots of total cellinducing only those genes responsive to this lower level.
lysates were probed with a polyclonal antibody raised against theComprehensive dose±response curves of gene induc-
extracellular domain of the human M-CSF receptor (Upstate Bio-
tion at varying levels of receptor activation will be re- technology, Lake Placid, NY).
quired to address this possibility. Alternatively, the dif-
ference might derive from differential signaling activities Northern Blots
Northern blots and hybridizations were performed by standard tech-of the EGFR (van der Geer et al., 1994). However, many
niques using 10 mg total RNA and radioactive probes generated byof the same signaling proteins are reported to bind to
random priming of sequence-verified PCR products.or be activated by both the EGFR and the PDGFR, in-
cluding PLCg, SHP2, RasGAP, and several SH2 adaptor
Preparation of Labeled Targets for Hybridizationproteins. There are differences in less well-character-
Cells were plated in DMEM (GIBCO) supplemented with 10% bovine
ized signaling pathways, such as sphingolipid metabo- calf serum (Sigma, St. Louis, MO) at 3 3 105 cells/100 mm plate and
lism (Olivera and Spiegel, 1993; Rani et al., 1997). passaged every 3 days. For RNA preps, confluent cells were rinsed
with PBS and incubated with DMEM 1 0.5% bovine calf serumIt will be important to probe the extent to which diverse
for 2 days, then rinsed again and stimulated with growth factor inRTKs send a generic signal, as well as the ways in
DMEM 1 0.5% bovine calf serum for the indicated times. Growthwhich a generic RTK signal induces distinct responses
factors (R&D Systems, Minneapolis, MN; Sigma) were used at thein different cells. Such investigations will require more
following concentrations determined to give maximal mitogenic ac-
extensive mix-and-match experiments in which multiple tivity: PDGF-BB, 40 ng/ml; M-CSF, 40 ng/ml; FGF4, 10 ng/ml; FGF1,
RTK receptors are systematically swapped among cell 10 ng/ml plus heparin (Sigma), 10 mg/ml; EGF, 25 ng/ml. CHX (Sigma)
was used at 10 mg/ml. IFNg (R&D Systems) was used at 1 ng/ml.types and expression is monitored.
Cells were lysed in Trizol (GIBCO), and RNA was prepared accordingIn summary, our results suggest a picture in which
to the manufacturer's instructions. Poly(A)1 RNA was purified usingRTKs transduce signals to the nucleus by employing
oligo-dT conjugated latex beads (Qiagen, Chatsworth, CA).multiple signaling pathways that largely integrate to
To prepare cRNA for hybridization, 1 mg poly(A)1 RNA or 20 mg
modulate the quantitative level of transcription of a total RNA (each method gave comparable results) was denatured
largely common group of IEGs. Of course, this is an at 708C with 0.1 nM T7-tagged oligo-dT primer (GGCCAGTGAATTGT
AATACGACTCACTATAGGGAGGCGG-T(24)), cooled on ice, then re-oversimplificationÐas evident from some of the detailed
verse transcribed with 400 U Superscript II at 378C (poly(A)1) or 428Cobservations above. Nonetheless, the question is whether
(total RNA) for 10 min in 13 first-strand buffer, 10 mM DTT, and 0.5this oversimplification captures enough of the key fea-
mM each dNTP, 20 ml total volume (all reagents, GIBCO). Second-tures in most cases to be a useful description.
strand cDNA was synthesized by adding 40 U DNA pol I, 10 U E.
coli DNA ligase, 2 U RNase H, 30 ml 53 second-strand buffer, 3 ml
10 mM each dNTP, and ddH20 to 150 ml final volume and incubatingExperimental Procedures
120 min at 168C (all reagents, GIBCO). The resulting cDNA was
extracted once with phenol/chloroform. One microgram of cDNAConstruction of the ChiR and Generation of ChiR-3T3 Cells
The ChiR gene was constructed from DNA encoding amino acids (for poly(A)1 RNA) or all the cDNA (for total RNA) was used for in
vitro transcription with a T7 RNA polymerase Megascript kit (Am-1±513 of the M-CSF receptor and amino acids 528±1106 of the
PDGFRb joined at an EcoRI site (Symes and Mercola, 1996). Muta- bion, Austin, TX) according to the manufacturer's instructions and
incorporating biotinylated CTP and UTP (Enzo, Farmingdale, NY)tions in the PDGFRb sequence are as described (Valius and Kaz-
lauskas, 1993). Constructs were assembled in the pLXSN retroviral 1:3 with unlabeled CTP and UTP. Labeled RNA was purified with
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RNeasy columns (Qiagen). Labeled RNA (45 mg) was fragmented in Fuller Fund and the Jane Coffin Childs Memorial Fund for Cancer
Research. This work was supported in part by a grant from Bristol-40 mM Tris-acetate 8.0, 100 mM KOAc, 30 mM MgOAc for 35 min
at 958C in 60 ml. Fragmented RNA was brought to 900 ml with final Myers Squibb, Millennium Pharmaceuticals, and Affymetrix.
concentrations of 13 STT (1 M NaCl, 10 mM Tris 8.0, 0.01% Triton-X
100), 100 mg/ml herring sperm DNA, and 50 pM biotinylated control Received February 16, 1999; revised May 7, 1999.
oligo 948 (Affymetrix, Santa Clara, CA).
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